Toronto, Ontario and Boston, Massachusetts–(Newsfile Corp. – March 4, 2026) – Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (“Sernova” or the “Company”), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced financing transactions totaling $7.1 million, …
Read More »
Matribhumi Samachar English